top of page
Connecting Rare Disease Patients to the Medicine They Need.
30
Million Americans
10,000
Rare Diseases
350
Million Patients Worldwide
What we do
We work with patient groups, pharmaceutical companies and academia to bridge the gap between rare disease patients and the medicine they need.
How we do it
Utilizing an AI-enabled, advanced technology platform, we facilitate the development, formulation, and manufacturing of active pharmaceutical ingredients. The on-demand platform is a viable, domestic solution for drug repurposing, clinical trials and small patient populations, specifically rare diseases.
Rare Remedy Partners
Academic Institutions
Clinical Trials
Patient Advocacy Organizations
bottom of page